Searching for a Pulse
We're having a standard sell-the-news reaction to this morning's jobs report, but in view of how Thursday's ADP (ADP) report raised expectations, I can't say it's a surprise. We seem to have some bids under the market, and breadth isn't bad at about 2100 gainers to 2900 to decliners.
The best sector of the day is biotechnology, with strength in Jazz Pharmaceuticals (JAZZ), Regeneron Pharmaceuticals (REGN), ViroPharma (VPHM) and Alexion Pharmaceuticals (ALXN). Retailers are marginally green, but big-caps are mixed, with recent leaders Google (GOOG) and Intuitive Surgical (ISRG) lagging, while laggards Amazon (AMZN) and Netflix (NFLX) are stepping up....77 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.
